Also, the blockade of CCR2 expression reduces tumor growth and inhibits the proliferation of cancer cells by influencing the PI3K/Akt and p38 MAPK signaling pathway in DLBCL (diffuse large B-cell lymphoma) [43]. This evidence concerns the gene CCR2 and diffuse large B-cell lymphoma.